JAM-A:在动脉样硬化中粘附受体和信号调节器
Mariel F Schwietzer1, Klaus Ebnet2
1Molecular Cardiology, Cardiology I, Medical Clinic C, University Hospital Münster, 48419, Münster, Germany.
Current atherosclerosis reports
|July 29, 2025
概括
连接粘附分子-A (JAM-A) 在动脉样硬化发展中至关重要. 它在内皮细胞上的再分配和从血小板释放促进炎症,血栓形成和疾病进展.
科学领域:
- 心血管生物学 心血管生物学
- 免疫学 免疫学 免疫学
- 细胞粘附 细胞粘附
背景情况:
- 细胞对细胞的粘附在血管炎症和血栓形成中至关重要.
- 交界粘附分子-A (JAM-A),一个免疫球蛋白超级家族受体,调解白细胞,血小板和内皮细胞相互作用.
研究的目的:
- 综合审查JAM-A在动脉样硬化中的作用.
- 阐明JAM-A对动脉动脉产生有所贡献的机制.
主要方法:
- 对血管生物学中JAM-A功能的现有文献的综述.
- 分析JAM-A的表达和局部化,以响应炎症刺激.
- 研究可溶性JAM-A (sJAM-A) 在血小板功能和聚合中的作用.
主要成果:
- 促炎性刺激会在内皮细胞上重新分配JAM-A,增强单细胞的粘附和转移.
- 血小板激活增加了表面JAM-A,并释放了sJAM-A,促进了血小板聚合和血栓形成.
- 升高的sJAM-A水平与复发性心肌梗塞相关,突出其临床相关性.
结论:
- JAM-A是动脉动脉生成的关键调解者,影响内皮细胞激活,血小板功能和白细胞招募.
- 了解JAM-A的机制为动脉样硬化和相关心血管疾病提供了潜在的治疗点.
相关概念视频
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
Atherosclerosis I: Introduction
87
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
87
Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Cell Adhesion Molecules - Types and Functions
7.4K
Cell adhesion molecules (CAMs) are pivotal to multicellularity and the coordinated functioning of tissues and organ systems. They enable physical interactions between cells and provide mechanical strength to tissues. They also function as receptors for signal transmission across the plasma membrane. The CAMs are broadly classified into four families - integrins, cadherins, selectins, and immunoglobulin-like CAMs (IgCAMs).
CAM Families
The Integrin family of proteins is primarily involved...
CAM Families
The Integrin family of proteins is primarily involved...
7.4K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
40
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
40


